ArticleAdvances in therapy2023

Current and Emerging Treatment Options for Patients with Metastatic EGFR-Mutated Non-small Cell Lung Cancer After Progression on Osimertinib and Platinum-Based Chemotherapy: A Podcast Discussion.

Sandip Patel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.